AMCHAM India
  • Home
  • About AMCHAM
    • About Us
    • National Executive Board
    • Secretariat
  • Membership
    • Membership
    • Membership Benefits
    • Pay Now
  • Committees
  • Events
    • Upcoming Events
    • Past Events
  • Communication
    • Publications
    • Annual Report
    • Newsletter Archive
  • Advocacy
  • Contact
Select Page

AmCham submitted comments on the Proposed Revised Guidelines for Similar Biologics to Drugs Controller General India (DCGI)

May 19, 2016 | Pharma Committee

These recommendations were submitted by AmCham Pharma Committee to Drugs Controller General India (DCGI) on 26th April 2016.

Copyrights 2021 - 2022. The American Chamber of Commerce In India. Designed & Developed by Crazy Nib